NASDAQ:EPOC - Epocrates Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$11.73
Today's RangeN/A
52-Week Range$6.90 - $11.97
VolumeN/A
Average Volume228,735 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Epocrates, Inc. (Epocrates) is a provider of mobile drug reference tools and electronic health records to healthcare professionals and interactive services to the healthcare industry. As of December 31, 2011, its user network consists of well over one million healthcare professionals, including approximately 340,000, or more than 50% of United States physicians. The Company offers its products on major United States mobile platforms, including Apple iOS, Android and BlackBerry. Epocrates operates in two segments: Subscriptions and Interactive Services, and Electronic Health Records. It uses brand names include DocAlert, Epocrates, Epocrates Honors, Epocrates ID, Epocrates Lab, Epocrates MedTools, Epocrates Rx, Epocrates Rx Pro, Epocrates Dx, Epocrates QuickSurvey, Epocrates QuickRecruit, Epocrates MedInsight, EssentialPoints and MedCafe. In October 2011, it launched a redesign of the drug reference tool to create a new platform that provides healthcare professionals.

Receive EPOC News and Ratings via Email

Sign-up to receive the latest news and ratings for EPOC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:EPOC
CUSIPN/A
Phone+1-415-4163500

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Epocrates (NASDAQ:EPOC) Frequently Asked Questions

What is Epocrates' stock symbol?

Epocrates trades on the NASDAQ under the ticker symbol "EPOC."

Has Epocrates been receiving favorable news coverage?

Press coverage about EPOC stock has trended positive on Monday, according to InfoTrie. The research group identifies negative and positive media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Epocrates earned a daily sentiment score of 3.0 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the near future.

How do I buy shares of Epocrates?

Shares of EPOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Epocrates' official website?

The official website for Epocrates is http://www.epocrates.com.

How can I contact Epocrates?

Epocrates' mailing address is 50 Hawthorne, SAN FRANCISCO, CA 94105, United States. The company can be reached via phone at +1-415-4163500.


MarketBeat Community Rating for Epocrates (NASDAQ EPOC)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  85 (Vote Outperform)
Underperform Votes:  79 (Vote Underperform)
Total Votes:  164
MarketBeat's community ratings are surveys of what our community members think about Epocrates and other stocks. Vote "Outperform" if you believe EPOC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EPOC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/25/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel